Requirement for early donor cell chimerism during prolonged survival of murine skin allografts

Transplantation

Volumn 69, Issue 8, 2000, Pages 1667-1675

  Masli, Sharmila ^a,b   De Fazio, Sally R ^a   Gozzo, James J ^a,c  

^a NORTHEASTERN UNIVERSITY   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; LYMPHOCYTE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CHIMERA; CONTROLLED STUDY; DENDRITIC CELL; GRAFT SURVIVAL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLOGRAFT;

EID: 0034720071     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004270-00024     Document Type: Article

References (46)

1. Use of allogeneic homozygous bone marrow cells for the induction of specific immunologic tolerance in mice treated with antilymphocyte serum
2. Prolongation of renal allograft survival in antilymphocyte serum-treated dogs by postoperative injection of density-gradient-fractionated donor bone marrow
3. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys
4. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice
5. Splenic suppressor cells in allograft recipients treated with ALS and donor bone marrow cells
6. The veto mechanism in transplant tolerance
7. Donor cell chimerism permitted by immunosuppressive drugs: A new view of organ transplantation
8. Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: A 44 month follow-up
9. The lost chord: Microchimerism and allograft survival
10. Chimerism and transplantation tolerance
11. Microchimerism: A state of low ratio proliferation of allogeneic bone marrow
12. Assessment of donor bone marrow cell-derived chimerism in transplantation tolerance using transgenic mice
13. The veto mechanism in transplant tolerance
14. Peripheral blood chimerism in renal allograft recipients transfused with donor bone marrow
15. The requirement for allogeneic chimerism for second transfer of tolerance from mixes allogeneic chimeras (A+B -A) to secondary recipients
16. Mixed allogeneic chimeras prepared by a non-myeloablative regimen: Requirement for chimerism to maintain tolerance
17. Specificity requirement of donor bone marrow cells (BMC) which prolong allograft survival: Implications for a veto cell mechanism of action
18. Effect of asialofetuin on prolongation of skin allograft survival by donor bone marrow cells
19. Use of minimal doses lymphoid cells for production of heterologous antilymphocyte serum
20. Effect of monoclonal anti-CD4 and anti-CD8 on skin allograft survival on mice treated with donor bone marrow cells
21. Prolongation of adult skin allograft survival by co-transplantation of neonatal skin in antilymphocyte serum-and donor bone marrow cell-treated mice
22. A method for rapid graphic solution of time-percent effect curves
23. Prolongation of graft survival in ALS-treated mice by donor-specific bone marrow: Density gradient fractionation of the active bone marrow cells
24. Isolation by continuous density gradient centrifugation and characterization of bone marrow cells active in prolonging allograft survival in antilymphocyte serum (ALS)-treated mice
25. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
26. Stimulatory and inhibitory interaction of granulocyte-macrophage colony-stimulating factor with other cytokines
27. Dendritic cells and tolerance induction
28. Expression of dendritic cell markers on bone marrow cells in a fraction enriched fo the ability to prolong skin allograft survival in ALS-treated murine recipients
29. Developmental pathways of dendritic cells in vivo: Distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice
30. In vivo depletion of CD4- and CD8 specific T cells
31. Functional relevance of donor-derived hematopoietic microchimerism only for induction phase of allograft acceptance (Abstract 46)
32. Functional characteristics of a Ficoll-separated mouse bone marrow cell population involved in skin allograft prolongation
33. Mouse skin graft prolongation with donor strain bone marrow and antilymphocyte serum: Surface markers of the active bone marrow cell
34. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism
35. Effect of granulocyte-macrophage colony-stimulating factor on the induction of unresponsiveness by lymphoid cells
36. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo
37. Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation
38. Dendritic cell/ dendritic cell interactons in primary immune responses
39. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes
40. A subclass of dendritic cells kills CD4 T cells via Fas/Fas-lignd induced apoptosis
41. The effect of cyclosporine on the induction of unresponsiveness in antilymphocyte serum-treated, marrow-injected mice
42. Induction of allograft tolerance with neonatal skin
43. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with ALS and donor bone marrow cells
44. Prolongation of skin allograft survival by cotransplantation of UVB-irradiated skin
45. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients
46. High-dose donor bone marrow infusions to enhance allograft survival. Effect of timing